Bendamustine in patients with relapsed or refractory multiple myeloma

OBJECTIVE: In patients with multiple myeloma, bendamustine monotherapy is effective as 1(st )and 2(nd )line therapy. However, data for patients with advanced multiple myeloma is rare. METHODS: In this retrospective analysis we have identified 39 patients with relapsed or refractory multiple myeloma...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, M, Bruns, I, Bölke, E, Zohren, F, Czibere, A, Safaian, N N, Neumann, F, Haas, R, Kobbe, G, Fenk, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351842/
https://www.ncbi.nlm.nih.gov/pubmed/20159666
http://dx.doi.org/10.1186/2047-783X-15-1-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351842/
https://www.ncbi.nlm.nih.gov/pubmed/20159666
http://dx.doi.org/10.1186/2047-783X-15-1-13

Ejemplares similares